Your browser doesn't support javascript.
loading
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor.
Litchfield, Kevin; Levy, Max; Orlando, Giulia; Loveday, Chey; Law, Philip J; Migliorini, Gabriele; Holroyd, Amy; Broderick, Peter; Karlsson, Robert; Haugen, Trine B; Kristiansen, Wenche; Nsengimana, Jérémie; Fenwick, Kerry; Assiotis, Ioannis; Kote-Jarai, ZSofia; Dunning, Alison M; Muir, Kenneth; Peto, Julian; Eeles, Rosalind; Easton, Douglas F; Dudakia, Darshna; Orr, Nick; Pashayan, Nora; Bishop, D Timothy; Reid, Alison; Huddart, Robert A; Shipley, Janet; Grotmol, Tom; Wiklund, Fredrik; Houlston, Richard S; Turnbull, Clare.
Afiliação
  • Litchfield K; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Levy M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Orlando G; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Loveday C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Law PJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Migliorini G; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Holroyd A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Broderick P; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Karlsson R; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Haugen TB; Faculty of Health Sciences, Oslo and Akershus University College of Applied Sciences, Oslo, Norway.
  • Kristiansen W; Faculty of Health Sciences, Oslo and Akershus University College of Applied Sciences, Oslo, Norway.
  • Nsengimana J; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds, UK.
  • Fenwick K; Tumour Profiling Unit, The Institute of Cancer Research, London, UK.
  • Assiotis I; Tumour Profiling Unit, The Institute of Cancer Research, London, UK.
  • Kote-Jarai Z; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Muir K; Division of Health Sciences, Warwick Medical School, Warwick University, Warwick, UK.
  • Peto J; Institute of Population Health, University of Manchester, Manchester, UK.
  • Eeles R; Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Easton DF; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Dudakia D; Royal Marsden NHS Foundation Trust, London, UK.
  • Orr N; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Pashayan N; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Bishop DT; Department of Applied Health Research, University College London, London, UK.
  • Shipley J; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds, UK.
  • Grotmol T; Academic Uro-oncology Unit, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
  • Wiklund F; Academic Radiotherapy Unit, Institute of Cancer Research, Sutton, Surrey, UK.
  • Houlston RS; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Turnbull C; Cancer Registry of Norway, Oslo, Norway.
Nat Genet ; 49(7): 1133-1140, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28604728
ABSTRACT
Genome-wide association studies (GWAS) have transformed understanding of susceptibility to testicular germ cell tumors (TGCTs), but much of the heritability remains unexplained. Here we report a new GWAS, a meta-analysis with previous GWAS and a replication series, totaling 7,319 TGCT cases and 23,082 controls. We identify 19 new TGCT risk loci, roughly doubling the number of known TGCT risk loci to 44. By performing in situ Hi-C in TGCT cells, we provide evidence for a network of physical interactions among all 44 TGCT risk SNPs and candidate causal genes. Our findings implicate widespread disruption of developmental transcriptional regulators as a basis of TGCT susceptibility, consistent with failed primordial germ cell differentiation as an initiating step in oncogenesis. Defective microtubule assembly and dysregulation of KIT-MAPK signaling also feature as recurrently disrupted pathways. Our findings support a polygenic model of risk and provide insight into the biological basis of TGCT.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Neoplasias Embrionárias de Células Germinativas / Estudo de Associação Genômica Ampla Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Neoplasias Embrionárias de Células Germinativas / Estudo de Associação Genômica Ampla Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article